Canonical Wnt Signaling Promotes Neovascularization Through Determination of Endothelial Progenitor Cell Fate via Metabolic Profile Regulation

Authors:

Abstract
Endothelial progenitor cells (EPC) contribute to blood vessel formation. Canonical Wnt signaling plays an important role in physiological and pathological angiogenesis and EPC fate regulation. However, the mechanism for Wnt signaling to regulate EPC fate in neovascularization has not been clearly defined. Here we showed that very low‐density lipoprotein receptor knockout (Vldlr−/−) mice, a model of ocular neovascularization induced by Wnt signaling over‐activation, have increased EPC numbers in the bone marrow, blood and retina, as well as an elevated mitochondrial membrane potential indicating higher mitochondrial function of EPC in the circulation. Isolated EPC from Vldlr−/− mice showed over‐activated Wnt signaling, correlating with increased mitochondrial function, mass and DNA copy numbers, compared to WT EPC. Our results also demonstrated that Wnt signaling up‐regulated mitochondrial biogenesis and function, while inhibiting glycolysis in EPC, which further decreased EPC stemness and promoted EPC to a more active state toward differentiation, which may contribute to pathologic vascular formation. Fenofibric acid, an active metabolite of fenofibrate, inhibited Wnt signaling and mitochondrial function in EPC and decreased EPC numbers in Vldlr−/−mice. It also decreased mitochondrial biogenesis and ROS production in Vldlr−/− EPC, which may be responsible for its therapeutic effect on diabetic retinopathy. These findings demonstrated that Wnt signaling regulates EPC fate through metabolism, suggesting potential application of the EPC metabolic profile as predictor and therapeutic target for neovascular diseases. Significance Statement Dysregulated blood vessel formation is an important pathological feature in multiple diseases, such as neovascular eye diseases and cancer. Endothelial progenitor cells (EPC) are generated in the bone marrow, transported to target tissues through the blood, and differentiate into endothelial cells to form new vessels. This study found that EPC metabolic profile is a direct determinant of EPC fate. The Wnt signaling pathway regulates EPC metabolism, EPC fate and subsequently, new vessel formation. These findings reveal a new function of Wnt signaling in regulating mitochondrial function in EPC. This study also suggests a potential significance of EPC metabolic profile as a diagnostic marker and therapeutic target for diseases caused by abnormal blood vessel formation. © AlphaMed Press 2019
Funding Information
  • Natural Science Foundation of Tianjin, China (15JCQNJ11400)
  • Oklahoma Center for the Advancement of Science and Technology (HR16-041)
  • Juvenile Diabetes Research Foundation (2-SRA-2014-147-Q-R)
  • National Institutes of Health (GM122744, EY028949, EY012231, EY019309, EY018659)
  • Natural Science Foundation of Tianjin Municipality (15JCQNJ11400)
  • Oklahoma Center for the Advancement of Science and Technology (HR16‐041)
  • National Institutes of Health (GM122744, EY028949, EY012231, EY019309, EY018659)

This publication has 57 references indexed in Scilit: